Lung toxicity of hydroxypropyl-β-cyclodextrin infusion

Molecular Genetics and Metabolism

Volumn 109, Issue 2, 2013, Pages 231-232

  Chien, Yin Hsiu ^a,c   Shieh, Yih Dar ^a,c   Yang, Chi Yu ^b   Lee, Ni Chung ^a,c   Hwu, Wuh Liang ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c ANIMAL TECHNOLOGY INSTITUTE TAIWAN   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN;

CENTRAL NERVOUS SYSTEM DISEASE; DRUG DOSE REDUCTION; DRUG INFUSION; DRUG SAFETY; HEPATOSPLENOMEGALY; HUMAN; LETTER; LUNG FIBROSIS; LUNG TOXICITY; NIEMANN PICK DISEASE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR;

BETA-CYCLODEXTRINS; FEMALE; HUMANS; NIEMANN-PICK DISEASE, TYPE C;

EID: 84878507061     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.04.003     Document Type: Letter

References (4)

1. Matsuo M., Togawa M., Hirabaru K., Mochinaga S., Narita A., Adachi M., Egashira M., Irie T., Ohno K. Effects of cyclodextrin in two patients with Niemann-Pick type C disease. Mol. Genet. Metab. 2013, 108:76-81.
2. Davidson C.D., Ali N.F., Micsenyi M.C., Stephney G., Renault S., Dobrenis K., Ory D.S., Vanier M.T., Walkley S.U. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One 2009, 4:e6951.
3. Gould S., Scott R.C. 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review. Food Chem. Toxicol. 2005, 43:1451-1459.
4. Ward S., O'Donnell P., Fernandez S., Vite C.H. 2-Hydroxypropyl-beta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease. Pediatr. Res. 2010, 68:52-56.